steatosis

steatosis

 英

  • n.脂肪變性;皮脂腺病
  • 網絡脂肪肝;脂肪化變性;單純性脂肪肝

英漢解釋

n.
1.
脂肪變性
2.
皮脂腺病

例句

A few patients with simple steatosis may progress but the majority of them will not progress in terms of their liver disease.

單純脂肪變性患者小部分進展絕大多數不會發生肝病進展

Conversely, a normal MRI scan can exclude hepatic steatosis , but an abnormal MRI scan is not a reliable indicator of fatty change.

相反正常MRI排除肝臟脂肪變性但是一個異常MRI掃描不是脂肪改變可靠指標

Moreover, it has been shown to induce steatosis, modulate apoptosis, and increase cellular oncogenic potential.

引起脂肪變性調節細胞凋亡增加細胞致癌

Conclusions Steatosis is an important risk factor in living donor liver transplantation.

結論脂肪變性程度影響受體并發癥生存重要因素

The independent risk factors for significant steatosis were older age, obesity and hypertriglyceridemia.

嚴重脂肪變性獨立危險因素包括高齡肥胖甘油三

In patients with NAFLD, daily fructose ingestion is associated with reduced hepatic steatosis but increased fibrosis.

結論NAFLD患者每日攝入一定果糖可以肝臟脂肪程度減輕但是肝臟纖維化程度增加

Moderate and heavy hepatic steatosis can be used in the liver transplantation.

細胞脂肪可用

However, US cannot detect small amounts of hepatic steatosis and cannot establish the diagnosis of NASH or stage of hepatic fibrosis.

然而US不能檢測少量肝臟脂肪變性不能用于NASH診斷肝炎分期

Objective To evaluate the value of medical imaging technology in qualitative and quantitative diagnosis of liver steatosis .

目的評價影像學技術脂肪變性定性定量診斷價值

However, the lack of sonographic evidence of steatosis cannot definitively exclude the presence of mild steatosis, as shown on biopsy.

但是缺乏脂肪變性超聲證據不能完全排除穿顯示出輕微脂肪存在

However, US can accurately estimate the severity of the steatosis .

但是US可以精確地測量脂肪變性嚴重程度

The authors note that NAFLD was the most common cause (81. 5%) of hepatic steatosis on ultrasound.

作者認為NAFLD超聲掃描肝臟脂肪變性常見致病因素(81.5%)。

Methods: We retrospectively analyzed these clinical courses of 270 patients. Results: Hepatic steatosis was noted in 60 patients.

方法回顧總結270肝癌肝切除患者臨床病理資料相關指標進行統計學分析

In the third study, it is shown that liver steatosis needs higher spatial resolution of ultrasound for more accurate characterization.

第三研究指出肝臟脂肪變性程度需要解析高頻音波才能較高分類準確度

The hepatic steatosis degree were lighten obviously (P01).

肝臟程度顯著減輕(P0.01)。

Patr 4. On the basis of part 3, the underlying mechanisms of main components of GST for ameliorating hepatocyte steatosis were investigated.

第3部分研究基礎探討中藥GST主要成分防治肝細胞脂肪變性機制

Animals developed 30 to 60% steatosis.

30%60%動物脂肪變性

abstract: Objective To study the effects of mogrosides(Mog) on hepatocyte steatosis induced by tetracycline in vitro.

目的探討羅漢果誘導肝細胞脂肪變性影響

Study of ultrasonic integrated backscatter on experimental hepatic steatosis model in rabbits

家兔脂肪超聲背向散射積分研究

Establishment of experimental hepatic steatosis model in rabbits and non-invasive quantitative ultrasonic diagnosis of fatty liver disease

飲酒建立家兔脂肪模型超聲量化診斷

Primary ultrasonographic evaluation of hepatic steatosis in the liver graft before transplantation

移植超聲快速評價脂肪變性初步研究

Laboratory diagnosis of hepatic steatosis

脂肪肝病實驗室診斷

Effect of simvastatin on experimental liver steatosis in rats

實驗脂肪影響

Protection of nitric oxide for hepatic steatosis caused by total parenteral nutrition in rats

一氧化胃腸外營養脂肪變性保護作用

Protective role of arginine in hepatic steatosis caused by total parenteral nutrition in rats

氨酸胃腸外營養脂肪變性保護作用

熱門查詢